China Immunotech (Beijing) Biotechnology
Organisation
Trials
A Clinical Study of YTS109 Cell in R/R Systemic Lupus Erythematosus
Phase 1, Terminated, 2 people, 25 Apr 2025
Collaborator, Phase 2, Status unknown, 20 people, 27 Aug 2018
Sources: clinicaltrials.gov